Beta-Thalassemia, Hyperlipoproteinemia(a), And Metabolic Syndrome: Its Low-Cost Holistic Therapy
- 1 March 2007
- journal article
- case report
- Published by Mary Ann Liebert Inc in The Journal of Alternative and Complementary Medicine
- Vol. 13 (2) , 287-290
- https://doi.org/10.1089/acm.2006.6359
Abstract
Metabolic syndrome (MS) is an emerging global health problem. Although studies highlighting its genetic, lipid, and cardiometabolic associations have been described in detail, the exact cause for these associations is not clear. The authors describe, in this study, the case of a patient who, along with his family members, had clinical evidence of MS. In addition, this patient also exhibited beta-thalassemia minor and hyperlipoproteinemia(a). Lipoprotein [Lp(a)] levels diminished significantly following therapy with bark-stem powder of Terminalia arjuna, an ancient remedy recommended for angina pectoris. The co-existence of these conditions, reflecting both a genetic link and a significant reduction in Lp(a) levels amounting to 24.71% following the administration of T. arjuna, prompted the authors to report on this case.Keywords
This publication has 5 references indexed in Scilit:
- Metabolic Syndrome and Development of Diabetes Mellitus: Application and Validation of Recently Suggested Definitions of the Metabolic Syndrome in a Prospective Cohort StudyAmerican Journal of Epidemiology, 2002
- Influence of β0-Thalassemia on the Phenotypic Expression of Heterozygous Familial HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- The β-ThalassemiasNew England Journal of Medicine, 1999
- Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore.Journal of Epidemiology and Community Health, 1997
- Lp(a) lipoprotein: An overviewChemistry and Physics of Lipids, 1994